Literature DB >> 18242816

It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood.

Marina R Picciotto1, Nii A Addy, Yann S Mineur, Darlene H Brunzell.   

Abstract

Nicotine can both activate and desensitize/inactivate nicotinic acetylcholine receptors (nAChRs). An ongoing controversy in the field is to what extent the behavioral effects of nicotine result from activation of nAChRs, and to what extent receptor desensitization is involved in these behavioral processes. Recent electrophysiological studies have shown that both nAChR activation and desensitization contribute to the effects of nicotine in the brain, and these experiments have provided cellular mechanisms that could underlie the contribution of both these processes to nicotine-mediated behaviors. For instance, desensitization of nAChRs may contribute to the salience of environmental cues associated with smoking behavior and activation and desensitization of nAChRs may contribute to both primary and conditioned drug reward. Similarly, studies of the antidepressant-like effects of nicotinic agents have revealed a balance between activation and desensitization of nAChRs. This review will examine the evidence for the contribution of these two very different consequences of nicotine administration to behaviors related to nicotine addiction, including processes related to drug reinforcement and affective modulation. We conclude that there are effects of nAChR activation and desensitization on drug reinforcement and affective behavior, and that both processes are important in the behavioral consequences of nicotine in tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242816      PMCID: PMC2390914          DOI: 10.1016/j.pneurobio.2007.12.005

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  169 in total

1.  Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.

Authors:  R Reitstetter; R J Lukas; R Gruener
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

Review 2.  Volume transmission in the CNS and its relevance for neuropsychopharmacology.

Authors:  M Zoli; A Jansson; E Syková; L F Agnati; K Fuxe
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

Review 3.  Presynaptic nicotinic ACh receptors.

Authors:  S Wonnacott
Journal:  Trends Neurosci       Date:  1997-02       Impact factor: 13.837

4.  Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines.

Authors:  V J Djurić; E Dunn; D H Overstreet; A Dragomir; M Steiner
Journal:  Physiol Behav       Date:  1999-10

Review 5.  Neuronal nicotinic receptors: molecular organization and regulations.

Authors:  J L Galzi; J P Changeux
Journal:  Neuropharmacology       Date:  1995-06       Impact factor: 5.250

6.  Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.

Authors:  D C Perry; M I Dávila-García; C A Stockmeier; K J Kellar
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

Review 7.  Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.

Authors:  S M Dursun; S Kutcher
Journal:  Med Hypotheses       Date:  1999-02       Impact factor: 1.538

8.  Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement.

Authors:  T Kinnunen; K Doherty; F S Militello; A J Garvey
Journal:  J Consult Clin Psychol       Date:  1996-08

9.  Varying nicotine patch dose and type of smoking cessation counseling.

Authors:  D E Jorenby; S S Smith; M C Fiore; R D Hurt; K P Offord; I T Croghan; J T Hays; S F Lewis; T B Baker
Journal:  JAMA       Date:  1995-11-01       Impact factor: 56.272

10.  Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

Authors:  R J Salín-Pascual; J R de la Fuente; L Galicia-Polo; R Drucker-Colín
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more
  223 in total

1.  Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.

Authors:  Olivier George; Allison Lloyd; F Ivy Carroll; M Imad Damaj; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

Review 2.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

3.  Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.

Authors:  Amir H Rezvani; Marty Cauley; Hannah Sexton; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

4.  Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice.

Authors:  Yann S Mineur; Tenna N Mose; Sam Blakeman; Marina R Picciotto
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

5.  Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist.

Authors:  Mark G LeSage; David Shelley; Marco Pravetoni; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2012-04-04       Impact factor: 3.533

6.  Nicotinic neuromodulation in auditory cortex requires MAPK activation in thalamocortical and intracortical circuits.

Authors:  Irakli Intskirveli; Raju Metherate
Journal:  J Neurophysiol       Date:  2012-02-22       Impact factor: 2.714

Review 7.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 8.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 9.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 10.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.